Jeifer Biotech is excited to announce the launch of the ultra-pure spironolactone API, an advanced substance for precise endocrine and cardiovascular treatments.
This new type of product has a purity of 99.95%, ultra-low contaminants, enhanced stability, and meets the strict requirements of modern precision medicine and clinical applications in children and adults. Our GMP-certified facilities are currently in full operation, providing services to international pharmaceutical companies, contract development companies and healthcare distributors.
In Jeifer Biotech launch indicates that we are committed to advancing the innovation of the steroid apis, and provide the reliable, high-performance solution, to improve the effect of the treatment of patients with global.